/Investor DB

eureKARE

Venture capital

Seed

Find your way into eureKARE

Sign up to see every warm intro you have to eureKARE

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the eureKARE team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

eureKARE invests in synthetic biology and microbiome research and the intersection between the two, viewing Europe's strength in fundamental sciences as underexploited. It aims to support the commercialization efforts of European, UK, and Israeli scientists, helping create new companies, jobs, and industries. The firm sees applications across healthcare (cell therapies, microbiome-based medicine, gene therapies), agriculture, energy, and environmental sustainability (biofuels, biodiversity conservation, pollution control). Its mission is to identify and back companies developing cutting-edge synthetic biology technologies with the potential to transform industries and contribute to a more sustainable and equitable world.

Source: firm website, verified Oct 25, 2026.

Stage
Seed
Instruments
Equity

Frequently asked questions

What stage does eureKARE invest at?
eureKARE invests at the Seed stage.
What sectors does eureKARE focus on?
eureKARE focuses on AgTech, Biotech, Climate Tech, Deep Tech, Energy, Healthtech.

Images

eureKARE photoeureKARE photo

Similar investors

Featured in lists